Imaging mass spectrometry assists in the classification of diagnostically challenging atypical Spitzoid neoplasms.
Authors
Lazova
R
Rossitza
,
Seeley
EH
Erin H
,
Kutzner
H
Heinz
,
Scolyer
RA
Richard A
,
Scott
G
Glynis
,
Cerroni
L
Lorenzo
,
Fried
I
Isabella
,
Kozovska
ME
Milena E
,
Rosenberg
AS
Arlene S
,
Prieto
VG
Victor G
,
Shehata
BM
Bahig M
,
Durham
MM
Megan M
,
Henry
G
Gina
,
Rodriguez-Peralto
JL
Jose L
,
Riveiro-Falkenbach
E
Erica
,
Schaefer
JT
Jochen T
,
Danialan
R
Richard
,
Fraitag
S
Sylvie
,
Vollenweider-Roten
S
Sonja
,
Sepehr
A
Alireza
,
Sangueza
M
Martin
,
Hijazi
N
Nouf
,
Corredoira
Y
Yamile
,
Kowal
R
Rachel
,
Harris
OM
Olga M
,
Bravo
F
Francisco
,
Boyd
AS
Alan S
,
Gueorguieva
R
Ralitza
,
Caprioli
RM
Richard M
.
Journal of the American Academy of Dermatology. 2016 8 5; ().
Journal of the American Academy of Dermatology. 2016 8 5; ().
Abstract
Previously, using imaging mass spectrometry (IMS), we discovered proteomic differences between Spitz nevi and Spitzoid melanomas.
Previously, using imaging mass spectrometry (IMS), we discovered proteomic differences between Spitz nevi and Spitzoid melanomas.